Detalles de la búsqueda
1.
Pembrolizumab for Previously Treated Advanced or Metastatic Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 37(1): 19-27, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30030817
2.
Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 37(6): 869, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30778866
3.
Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 36(4): 399-406, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29222670
4.
Choice of statistical model for cost-effectiveness analysis and covariate adjustment: empirical application of prominent models and assessment of their results.
Eur J Health Econ
; 17(8): 927-938, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26445961
Resultados
1 -
4
de 4
1
Próxima >
>>